Selnoflast for atherosclerosis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 4 Mar 2026: Trial registered, NCT07448038
  2. 5 Jun 2026: Trial started, NCT07448038

The trials

NCT07448038: A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

State
Under way
Phase
Phase 2
People
162 planned
Started
5 Jun 2026
Primary completion
31 Jan 2028
Arms
Selnoflast
Results
None posted
  1. 4 Mar 2026: Trial registered
  2. 5 Jun 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.